CA
NZ
UK
AU
IND
US
…
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Tenon Medical Inc (NASDAQ: TNON) is a publicly listed medical device company; public disclosures about its products and operations are limited. Its long-term growth could be driven by regulatory approvals, successful product commercialization, partnerships, and broader healthcare demand for innovative surgical or therapeutic devices, which may benefit from an aging population and higher procedure volumes.
Material risks include dependence on regulatory approval and commercialization execution, potential need for additional financing, manufacturing and reimbursement challenges, and substantial competition in the medical device sector.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -18.92M | -7.08M | -0.71M | - |
| Minority interest | 0.00M | 0.03M | 0.12M | - |
| Net income | -19.11M | -7.67M | -0.75M | - |
| Selling general administrative | 7.42M | 2.71M | 0.31M | - |
| Selling and marketing expenses | 7.83M | 2.14M | 0.03M | - |
| Gross profit | -0.64M | 0.11M | 0.03M | - |
| Reconciled depreciation | 0.29M | 0.11M | 0.00M | - |
| Ebit | -18.73M | -6.46M | -0.54M | -0.53M |
| Ebitda | -18.45M | -6.35M | -0.54M | - |
| Depreciation and amortization | 0.27M | 0.11M | -0.00M | - |
| Operating income | -18.73M | -6.46M | -0.54M | - |
| Other operating expenses | 19.42M | 6.62M | 0.58M | - |
| Interest expense | 0.35M | 0.62M | 0.17M | 0.00M |
| Net interest income | -0.35M | -0.62M | -0.17M | - |
| Income tax expense | 0.19M | 0.59M | 0.05M | - |
| Total revenue | 0.69M | 0.16M | 0.04M | - |
| Total operating expenses | 18.08M | 6.57M | 0.56M | - |
| Cost of revenue | 1.33M | 0.05M | 0.02M | - |
| Total other income expense net | -0.19M | -0.62M | -0.17M | - |
| Net income from continuing ops | -18.92M | -7.08M | -0.71M | - |
| Net income applicable to common shares | -18.92M | -7.05M | -0.59M | -0.51M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 6.34M | 11.09M | 9.27M | 0.39M | - |
| Other current assets | 0.38M | 0.13M | 0.09M | - | - |
| Total liab | 5.57M | 4.84M | 29.82M | 3.10M | - |
| Total stockholder equity | 0.78M | 6.25M | -20.55M | -4.42M | - |
| Deferred long term liab | - | 0.03M | 0.37M | 0.09M | - |
| Other current liab | 1.28M | 1.75M | 1.09M | 0.66M | - |
| Common stock | 0.00M | 0.01M | 0.00M | 0.00M | 0.00M |
| Capital stock | - | 0.01M | 0.00M | 0.00M | - |
| Retained earnings | -55.07M | -39.49M | -20.58M | -4.49M | -3.90M |
| Other liab | - | 1.62M | - | - | - |
| Other assets | - | 0.08M | 0.42M | 0.09M | - |
| Cash | 2.43M | 2.13M | 2.92M | 0.25M | - |
| Total current liabilities | 3.14M | 2.53M | 15.27M | 1.49M | 1.69M |
| Net debt | -0.57M | -1.22M | 11.70M | 0.33M | - |
| Short term debt | 1.43M | 0.23M | 13.71M | 0.24M | - |
| Short long term debt | - | - | 13.51M | 0.24M | - |
| Short long term debt total | 1.86M | 0.91M | 14.62M | 0.57M | - |
| Other stockholder equity | 55.89M | 34.74M | 0.11M | 0.13M | -0.03M |
| Property plant equipment | - | 1.67M | 1.18M | - | - |
| Total current assets | 3.89M | 9.35M | 7.67M | 0.30M | 0.27M |
| Net tangible assets | - | 6.25M | -20.55M | -4.42M | -3.88M |
| Short term investments | - | 6.44M | 4.40M | 0.00M | - |
| Net receivables | 0.53M | 0.23M | 0.08M | 0.01M | 0.05M |
| Long term debt | - | - | - | 0.33M | - |
| Inventory | 0.55M | 0.41M | 0.19M | 0.04M | 0.06M |
| Accounts payable | 0.43M | 0.55M | 0.48M | 0.59M | 0.45M |
| Accumulated other comprehensive income | -0.05M | -0.10M | -0.09M | -0.06M | - |
| Non currrent assets other | 0.85M | 0.08M | 0.42M | 0.09M | - |
| Non current assets total | 2.46M | 1.74M | 1.60M | 0.09M | - |
| Capital lease obligations | - | 0.91M | 1.11M | 0.00M | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -2.88M | -4.40M | -4.40M | -4.40M |
| Change to liabilities | 0.07M | 0.44M | 0.14M | 0.27M |
| Total cashflows from investing activities | -2.88M | -4.50M | -4.50M | -4.50M |
| Net borrowings | - | 11.83M | 0.31M | 0.32M |
| Total cash from financing activities | 14.11M | 11.47M | 0.25M | 0.32M |
| Change to operating activities | 2.03M | 0.21M | 0.15M | 0.11M |
| Net income | -18.92M | -7.08M | -0.71M | -0.51M |
| Change in cash | -0.79M | 2.67M | 0.09M | 0.09M |
| Begin period cash flow | 2.92M | 0.25M | 0.15M | - |
| End period cash flow | 2.13M | 2.92M | 0.25M | 0.15M |
| Total cash from operating activities | -12.03M | -4.29M | -0.17M | -0.24M |
| Issuance of capital stock | 14.14M | - | - | - |
| Depreciation | 0.29M | 0.11M | 0.11M | 0.11M |
| Change to inventory | -0.23M | -0.15M | 0.02M | -0.06M |
| Change to account receivables | -0.15M | -0.06M | 0.04M | -0.05M |
| Other cashflows from financing activities | -0.03M | 11.71M | 0.25M | -0.05M |
| Change to netincome | 4.88M | 2.19M | 0.06M | 0.01M |
| Capital expenditures | 0.85M | 0.10M | 0.10M | 0.10M |
| Change in working capital | 1.72M | 0.45M | 0.35M | - |
| Stock based compensation | 2.90M | 0.38M | 0.02M | - |
| Other non cash items | 1.98M | 1.85M | 0.17M | - |
| Free cash flow | -12.87M | -4.39M | -0.17M | - |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| TNON Tenon Medical Inc |
0.07 4.30% |
1.82 | - | - | 1.02 | 3.84 | 0.82 | -0.16 |
| ABT Abbott Laboratories |
-0.71 0.65% |
108.58 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
0.28 0.28% |
101.89 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-2.16 0.68% |
316.63 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
- -% |
47.31 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
| Name | Title | Year Born |
|---|---|---|
| Mr. Steven M. Foster | CEO & Chairman | 1967 |
| Mr. Richard Ginn | Founder, CTO & Director | 1966 |
| Mr. Steven M. Van Dick | Exec. VP of Fin. & Admin. and CFO | 1955 |
| Mr. Richard M. Ferrari | Exec. Chairman | 1954 |
| Mr. Richard M. Ferrari | Founder & Executive Chairman | 1954 |
| Mr. Steven M. Foster | CEO, President & Director | 1968 |
| Mr. Steven M. Van Dick | Executive VP of Finance & Administration and CFO | 1955 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.40%
Communication Services
-0.45%
Consumer Cyclical
-0.55%
Consumer Defensive
-0.01%
Energy
-0.01%
Financial Services
-0.40%
Financials
-0.15%
Healthcare
-1.15%
Industrials
-0.46%
Real Estate
-0.29%
Technology
-1.22%
Utilities
-0.10%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
+0.55%
Please wait processing your request...